KC

Ketan Chourasia

Active Director Director DIN 09616060
DIN 09616060 First appointment May 2022 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Ketan Chourasia

Data last updated:

Ketan Chourasia is a Director at Drugcine Pharma Private Limited (since 2022). The company operates in Chemicals.

DIN 09616060
Primary Designation Director
Industry Chemicals
First Appointment 23 May 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Drugcine Pharma Private Limited U24100MP2022PTC060999
Director23 May 20222022Active

Board colleagues of Ketan Chourasia

NameDINCompanyDesignation
Srajan Chourasia09616059Drugcine Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Drugcine Pharma Private Limited
Premium access

Shareholding and investment profile for Ketan Chourasia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ketan Chourasia

Ketan Chourasia currently holds 1 directorship: Drugcine Pharma Private Limited (Director, since 23 May 2022).

Ketan Chourasia was first appointed on 23 May 2022 as Director at Drugcine Pharma Private Limited.

The current boards of Ketan Chourasia's companies include Srajan Chourasia (Drugcine Pharma Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available